Back
NewAmsterdam Pharma Co NV Vs. uniQure NV Industry Stock Comparison
Sell
46
NAMS
NewAmsterdam Pharma Co NV
Last Price:
$25.90
Seasonality Move:
37.93%
Buy
64
QURE
uniQure NV
Last Price:
$17.91
Seasonality Move:
7.15%
Sell
46
NewAmsterdam Pharma Co NV (NAMS)
is a Sell
Is NewAmsterdam Pharma Co NV a Buy, Sell or Hold?
-
The current NewAmsterdam Pharma Co NV [NAMS] share price is $25.94. The Score for NAMS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
NAMS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
uniQure NV (QURE)
is a Buy
Is uniQure NV a Buy, Sell or Hold?
-
The current uniQure NV [QURE] share price is $17.94. The Score for QURE is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
QURE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NAMS Stock Price Chart
What is NewAmsterdam Pharma Co NV's stock price today?
-
The NewAmsterdam Pharma Co NV share price today is $25.94Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NAMS is experiencing slight buying pressure.
QURE Stock Price Chart
What is uniQure NV's stock price today?
-
The uniQure NV share price today is $17.94Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QURE is experiencing slight selling pressure.
NAMS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.2 | Buy |
| Relative Strength Index (14 RSI): | 62.17 | Buy |
| Chaikin Money Flow: | 112221 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.5 - 26.7) | Buy |
| Bollinger Bands (100): | (15.98 - 23.22) | Buy |
QURE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.53 | Buy |
| Relative Strength Index (14 RSI): | 74.54 | Buy |
| Chaikin Money Flow: | -110840 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.71 - 18.29) | Buy |
| Bollinger Bands (100): | (3.79 - 11.95) | Buy |
NAMS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.86 | Buy |
| 20-day SMA: | 24.58 | Buy |
| 50-day SMA: | 22.37 | Buy |
| 200-day SMA: | 19.72 | Buy |
| 8-day EMA: | 25.74 | Buy |
| 20-day EMA: | 24.72 | Buy |
| 50-day EMA: | 22.69 | Buy |
| 200-day EMA: | 19.45 | Buy |
QURE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.61 | Buy |
| 20-day SMA: | 15.28 | Buy |
| 50-day SMA: | 9.95 | Buy |
| 200-day SMA: | 6.74 | Buy |
| 8-day EMA: | 17.38 | Buy |
| 20-day EMA: | 15.19 | Buy |
| 50-day EMA: | 11.53 | Buy |
| 200-day EMA: | 8.08 | Buy |
NewAmsterdam Pharma Co NV Earnings Growth & NAMS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $0.08 per share.
uniQure NV Earnings Growth & QURE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.70 per share.
NewAmsterdam Pharma Co NV Technical Analysis
| Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
uniQure NV Technical Analysis
| Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||